[breadcrumb_custom]

Dexcom Inc (DXCM) Stock: A Year of Declines and Increases

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Dexcom Inc’s current trading price is -8.96% away from its 52-week high, while its distance from the 52-week low is 69.97%. The stock’s price range for this time frame has been between $74.75 and $139.55. The trading volume of the company’s shares in the Healthcare reached around 4.17 million for the day, which was evidently higher than the average daily volume of 3.07 million over the last three months.

The stock market performance of Dexcom Inc has been very steady. Over the last year, the company’s stock hit its highest at $139.55 on 07/28/23, while the lowest price during the same time frame was $74.75, recorded on 10/13/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

How Financial Performance Impacts Market Capitalization

Dexcom Inc (DXCM) has experienced a quarterly rise of 33.47% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 49.09B and boasts a workforce of 7600 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 107.27, with a change in price of +30.70. Similarly, Dexcom Inc recorded 4,010,491 in trading volume during the last 100 days, posting a change of +31.86%.

How DXCM’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for DXCM stands at 1.20. Similarly, the long-term debt-to-equity ratio is also 1.13.

DXCM Stock Stochastic Average

The raw stochastic average for Dexcom Inc over the last 50 days is presently at 75.99%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 69.70%. Further, the company’s Stochastic %K and %D values for the last 20 days were 58.61% and 40.35%, respectively.

DXCM Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a gain of 2.39%.However, over the last six months, we can see a weaker performance of 14.50%. Over the last 30 days, the price of DXCM has leaped by -2.04%. And in the last five days, it has surged by 3.63%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts